MSD Partners, L.P. - Q3 2017 holdings

$3.43 Billion is the total value of MSD Partners, L.P.'s 34 reported holdings in Q3 2017. The portfolio turnover from Q2 2017 to Q3 2017 was 33.3% .

 Value Shares↓ Weighting
SPY NewSPDR S&P 500 ETF TRcall$2,120,381,0008,440,000
+100.0%
61.90%
SPY BuySPDR S&P 500 ETF TRput$200,984,000
+53.6%
800,000
+47.9%
5.87%
-27.9%
MIC SellMACQUARIE INFRASTRUCTURE COR$156,125,000
-13.7%
2,162,991
-6.2%
4.56%
-59.5%
AABA SellALTABA INC$154,908,000
-36.5%
2,338,587
-47.8%
4.52%
-70.2%
SSNC SellSS&C TECHNOLOGIES HLDGS INC$107,209,000
-2.0%
2,670,208
-6.2%
3.13%
-54.0%
COTY  COTY INC$97,536,000
-11.9%
5,900,5230.0%2.85%
-58.7%
NXST SellNEXSTAR MEDIA GROUP INCcl a$87,048,000
-44.2%
1,397,247
-46.4%
2.54%
-73.8%
APO BuyAPOLLO GLOBAL MGMT LLC$67,274,000
+32.8%
2,235,009
+16.7%
1.96%
-37.7%
QSR SellRESTAURANT BRANDS INTL INC$60,098,000
-31.9%
940,800
-33.3%
1.75%
-68.1%
HALO  HALOZYME THERAPEUTICS INC$38,996,000
+35.5%
2,245,0000.0%1.14%
-36.5%
FUN SellCEDAR FAIR L Pdepositry unit$38,515,000
-66.6%
600,665
-62.4%
1.12%
-84.3%
FWONK  LIBERTY MEDIA CORP DELAWARE$38,090,000
+4.0%
1,000,0000.0%1.11%
-51.2%
REI  RING ENERGY INC$37,504,000
+11.5%
2,588,2660.0%1.10%
-47.7%
HRG SellHRG GROUP INC$32,817,000
-35.0%
2,102,335
-26.3%
0.96%
-69.5%
NGHC  NATIONAL GEN HLDGS CORP$22,215,000
-9.4%
1,162,5000.0%0.65%
-57.5%
ZIOP  ZIOPHARM ONCOLOGY INC$20,940,000
-1.3%
3,410,5000.0%0.61%
-53.7%
XOP NewSPDR SERIES TRUSTcall$20,454,000600,000
+100.0%
0.60%
BKEP  BLUEKNIGHT ENERGY PARTNERS L$18,561,000
-8.8%
3,256,3900.0%0.54%
-57.2%
NG  NOVAGOLD RES INC$17,445,000
-9.6%
4,234,1290.0%0.51%
-57.6%
TRCO  TRIBUNE MEDIA COcl a$14,914,000
+0.2%
365,0000.0%0.44%
-53.0%
GASS  STEALTHGAS INC$12,276,000
+1.8%
3,708,8190.0%0.36%
-52.3%
IPG  INTERPUBLIC GROUP COS INC$10,881,000
-15.5%
523,3950.0%0.32%
-60.3%
BMCH  BMC STK HLDGS INC$10,293,000
-2.3%
482,0880.0%0.30%
-54.2%
MRTN BuyMARTEN TRANS LTD$10,275,000
+25.0%
500,000
+66.7%
0.30%
-41.3%
JPM  JPMORGAN CHASE & CO$7,163,000
+4.5%
75,0000.0%0.21%
-50.9%
C  CITIGROUP INC$7,130,000
+8.8%
98,0230.0%0.21%
-49.0%
EZPW  EZCORP INCcl a non vtg$6,792,000
+23.4%
715,0000.0%0.20%
-42.3%
SYN  SYNTHETIC BIOLOGICS INC$3,843,000
+65.0%
4,118,4020.0%0.11%
-22.8%
FCSC  FIBROCELL SCIENCE INC$2,120,000
-23.7%
692,9600.0%0.06%
-64.2%
EGLTQ NewEGALET CORP$1,357,0001,060,100
+100.0%
0.04%
OGEN  ORAGENICS INC$724,000
+13.5%
1,725,0000.0%0.02%
-47.5%
NewNABRIVA THERAPEUTICS PLC$410,00050,000
+100.0%
0.01%
ITCI NewINTRA CELLULAR THERAPIES INC$394,00025,000
+100.0%
0.01%
APHB  AMPLIPHI BIOSCIENCES CORP$14,000
+16.7%
15,0110.0%0.00%
-100.0%
NEOS ExitNEOS THERAPEUTICS INC$0-67,600
-100.0%
-0.03%
VRTV ExitVERITIV CORP$0-28,383
-100.0%
-0.08%
KRNT ExitKORNIT DIGITAL LTD$0-103,300
-100.0%
-0.12%
CDZI ExitCADIZ INC$0-336,699
-100.0%
-0.28%
NYRT ExitNEW YORK REIT INC$0-746,800
-100.0%
-0.40%
VST ExitVISTRA ENERGY CORP$0-2,024,921
-100.0%
-2.12%
USFD ExitUS FOODS HLDG CORP$0-2,007,170
-100.0%
-3.40%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2017-11-14
Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
ZIOPHARM ONCOLOGY INC42Q3 202315.7%
JPMORGAN CHASE & CO42Q3 20232.3%
STEALTHGAS INC39Q3 20232.8%
COOPER STD HLDGS INC29Q2 20223.0%
CITIGROUP INC28Q3 20231.4%
NATIONAL GEN HLDGS CORP26Q3 202015.3%
MARTEN TRANS LTD26Q3 20191.1%
SYNTHETIC BIOLOGICS INC21Q2 20180.5%
COTY INC20Q4 20187.4%
BLUEKNIGHT ENERGY PARTNERS L19Q4 20171.7%

View MSD Partners, L.P.'s complete holdings history.

Latest significant ownerships (13-D/G)

View MSD Partners, L.P.'s complete significant-ownership history.

Latest filings
TypeFiled
40-APP2024-04-11
42024-03-08
13F-HR/A2024-02-20
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13
42023-12-14

View MSD Partners, L.P.'s complete filings history.

Compare quarters

Export MSD Partners, L.P.'s holdings